Skip to main content
Equibles
CME logo

CME · Cme Group Inc.

Track CME — free

Use CME with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$277.77 -8.68 (-3.03%) At close · Sep 2
S&P 500 member Russell 1000 member Rebalance outlook locked
Customer concentration — top 2 customers 25% of revenue

2 customers — 25% of revenue (first six months of 2026)

“The two largest resellers of our market data represented approximately 25% of our market data and information services revenue in the first six months of 2026.”

One customer — 10% of revenue (first six months of 2026)

“One individual firm represented at least 10% of our clearing and transaction fees in the first six months of 2026.”
View the 10-Q filed Jul 24, 2026
Market Cap
$103.32B
Shares
359.58M

CME metrics

82 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$277.77
Market cap
$103.32B

Price action

19 metrics
Price change (1W)
+3.3%
Price change (30D)
+7.6%
Price change (3M)
+14.3%
Price change (6M)
-11.9%
Price change (YTD)
+4.9%
Price change (1Y)
+7.5%
Trailing year
Price change (5Y)
+43.8%
52-week high
$326.46
52-week low
$218.58
Change from 52-week high
-12.3%
Change from 52-week low
+31.1%
Annualized volatility
23.8%
Beta
-0.3
RSI (14D)
71.9
Price vs SMA 50
+12.1%
Price vs SMA 200
+2.7%
Avg volume (3M)
3.06M
Relative volume
0.5
Average dollar volume
$770.75M

Company

3 metrics
Sector
Financial Services
Industry
Financial Data & Stock Exchanges
Shares outstanding
359.58M

Valuation

12 metrics
P / E (TTM)
24.3
Trailing earnings · reciprocal yield 4.1%
PEG ratio
9.8
EV / revenue
—
EV / EBITDA
37.0×
reciprocal yield 2.7%
EV / EBIT
—
P / sales
15.3×
reciprocal yield 6.6%
P / book
3.9
reciprocal yield 25.7%
FCF yield
4.1%
TTM · current market cap
Buyback yield
—
P / FCF
24.5
reciprocal yield 4.1%
P / operating cash flow
24.0
reciprocal yield 4.2%
Earnings yield
4.1%

Historical valuation

8 metrics
P / E historical average (3Y)
25.0×
reciprocal yield 4.0%
P / E historical average (5Y)
26.4×
reciprocal yield 3.8%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
3.9%
Trailing 12 months
Payout ratio
95.1%
Shareholder yield
3.9%
Dividend / share (TTM)
$11.25
Dividend growth YoY
+6.1%
Dividend growth streak
—
Last ex-dividend
2026-06-09

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-22

Profitability

9 metrics
Gross margin
—
Operating margin
65.1%
Trailing 12 months
Net margin
63.3%
Gross profit (TTM)
—
Operating profit (TTM)
$4.41B
Net income (TTM)
$4.29B
Trailing 12 months
Diluted EPS (TTM)
$11.79
FCF margin
62.2%
Effective tax rate
23.4%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+0.8%
Year over year
Net income growth YoY
+1.6%
Revenue (TTM)
$6.77B
Trailing 12 months
EPS growth YoY
+2.5%
Shares change YoY
+0.3%
Year over year · more shares
Revenue CAGR (3Y)
+9.1%
Revenue CAGR (5Y)
+6.0%
EPS CAGR (3Y)
+14.7%
EPS CAGR (5Y)
+13.7%
FCF CAGR (3Y)
+12.2%
FCF CAGR (5Y)
+10.7%

Quality

14 metrics
Return on equity
16.2%
Return on assets
2.2%
Debt / equity
—
Current ratio
1.0
EBITDA (TTM)
$2.75B
Free cash flow (TTM)
$4.21B
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
-0.6
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$2.14B
Total assets
$194.68B
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$4.31B
Capital expenditures (TTM)
$96.30M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$99.50M
R&D / revenue
—
Stock compensation / revenue
1.5%

Ownership (13F)

3 metrics
13F filers
1,696
13F filer change QoQ
-114
Institutional ownership
90.0%

Short interest

3 metrics
Short interest
1.4%
Latest settlement · 3.1 days to cover
Days to cover
3.1d
Short-squeeze score
49 / 100

Insider activity

2 metrics
Net insider buying (90D)
$77,933
Insider-sentiment score
75 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1156375 CUSIP 12572Q105 13F (30d) 1043 filings 992 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)